APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus Influenzae Type B Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Haemophilus Influenzae Type B Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173996700322 December 2025182 pages

Choose your research edition.

Industry ResearchHaemophilus Influenzae Type B Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus Influenzae Type B Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Haemophilus Influenzae Type B Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus Influenzae Type B Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus Influenzae Type B Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Haemophilus Influenzae Type B Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Haemophilus Influenzae Type B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Haemophilus Influenzae Type B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haemophilus Influenzae Type B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Haemophilus Influenzae Type B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Haemophilus Influenzae Type B Vaccine include Takeda Pharmaceuticals Company, Sanofi, Novartis, Merck, Lanzhou Institute of Biologica, GlaxoSmithKline, Walvax Biotechnology and Immunize BC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Haemophilus Influenzae Type B Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Haemophilus Influenzae Type B Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Haemophilus Influenzae Type B Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Haemophilus Influenzae Type B Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Haemophilus Influenzae Type B Vaccine Segment by Company

Takeda Pharmaceuticals Company

Sanofi

Novartis

Merck

Lanzhou Institute of Biologica

GlaxoSmithKline

Walvax Biotechnology

Immunize BC

Haemophilus Influenzae Type B Vaccine Segment by Type

Liquid Combination HIB

Liquid Monovalent HIB

Lyophilized Combination HIB

Lyophilized Monovalent HIB

Haemophilus Influenzae Type B Vaccine Segment by Application

Pharmaceutical and Biotechnology Companies

Hospital

Research Institutions

Academic Institutions

Other

Haemophilus Influenzae Type B Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Haemophilus Influenzae Type B Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Haemophilus Influenzae Type B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Haemophilus Influenzae Type B Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Haemophilus Influenzae Type B Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Haemophilus Influenzae Type B Vaccine Industry Trends Table 2. Haemophilus Influenzae Type B Vaccine Industry Drivers Table 3. Haemophilus Influenzae Type B Vaccine Industry Opportunities and Challenges Table 4. Haemophilus Influenzae Type B Vaccine Industry Restraints Table 5. Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers Table 9. Global Haemophilus Influenzae Type B Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Haemophilus Influenzae Type B Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Haemophilus Influenzae Type B Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Haemophilus Influenzae Type B Vaccine Manufacturers, Product Type & Application Table 13. Global Haemophilus Influenzae Type B Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Haemophilus Influenzae Type B Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Liquid Combination HIB Table 17. Major Manufacturers of Liquid Monovalent HIB Table 18. Major Manufacturers of Lyophilized Combination HIB Table 19. Major Manufacturers of Lyophilized Monovalent HIB Table 20. Global Haemophilus Influenzae Type B Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 22. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (k units) Table 23. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2021-2026) Table 24. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2027-2032) Table 25. Global Haemophilus Influenzae Type B Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2026) & (k units) Table 27. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2027-2032) & (k units) Table 28. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmaceutical and Biotechnology Companies Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Research Institutions Table 33. Major Manufacturers of Academic Institutions Table 34. Major Manufacturers of Other Table 35. Global Haemophilus Influenzae Type B Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 37. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (k units) Table 38. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2021-2026) Table 39. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2027-2032) Table 40. Global Haemophilus Influenzae Type B Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2026) & (k units) Table 42. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2027-2032) & (k units) Table 43. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2021-2026) Table 44. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2027-2032) Table 45. Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2026) & (k units) Table 47. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2021-2026) Table 48. Global Haemophilus Influenzae Type B Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Haemophilus Influenzae Type B Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Haemophilus Influenzae Type B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 52. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2027-2032) & (k units) Table 53. Europe Haemophilus Influenzae Type B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 55. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2027-2032) & (k units) Table 62. Global Haemophilus Influenzae Type B Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2021-2026) Table 66. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2027-2032) Table 67. Takeda Pharmaceuticals Company Company Information Table 68. Takeda Pharmaceuticals Company Business Overview Table 69. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolio Table 71. Takeda Pharmaceuticals Company Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Haemophilus Influenzae Type B Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolio Table 76. Sanofi Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Haemophilus Influenzae Type B Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novartis Haemophilus Influenzae Type B Vaccine Product Portfolio Table 81. Novartis Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Haemophilus Influenzae Type B Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merck Haemophilus Influenzae Type B Vaccine Product Portfolio Table 86. Merck Recent Development Table 87. Lanzhou Institute of Biologica Company Information Table 88. Lanzhou Institute of Biologica Business Overview Table 89. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolio Table 91. Lanzhou Institute of Biologica Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. Walvax Biotechnology Company Information Table 98. Walvax Biotechnology Business Overview Table 99. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolio Table 101. Walvax Biotechnology Recent Development Table 102. Immunize BC Company Information Table 103. Immunize BC Business Overview Table 104. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolio Table 106. Immunize BC Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Haemophilus Influenzae Type B Vaccine Distributors List Table 110. Haemophilus Influenzae Type B Vaccine Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Vaccine Product Image Figure 2. Global Haemophilus Influenzae Type B Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Haemophilus Influenzae Type B Vaccine Sales (2021-2032) & (k units) Figure 5. Global Haemophilus Influenzae Type B Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Haemophilus Influenzae Type B Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Liquid Combination HIB Image Figure 9. Liquid Monovalent HIB Image Figure 10. Lyophilized Combination HIB Image Figure 11. Lyophilized Monovalent HIB Image Figure 12. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Haemophilus Influenzae Type B Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2021-2032) Figure 15. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2021-2032) Figure 18. Pharmaceutical and Biotechnology Companies Image Figure 19. Hospital Image Figure 20. Research Institutions Image Figure 21. Academic Institutions Image Figure 22. Other Image Figure 23. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Haemophilus Influenzae Type B Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2021-2032) Figure 26. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2021-2032) Figure 29. North America Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2032) Figure 31. U.S. Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2032) Figure 36. Germany Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2032) Figure 43. China Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2032) Figure 51. Brazil Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Haemophilus Influenzae Type B Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Haemophilus Influenzae Type B Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. North America Haemophilus Influenzae Type B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. Europe Haemophilus Influenzae Type B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Haemophilus Influenzae Type B Vaccine Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Haemophilus Influenzae Type B Vaccine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Combination HIB
  • Liquid Monovalent HIB
  • Lyophilized Combination HIB
  • Lyophilized Monovalent HIB
Applications
  • Pharmaceutical and Biotechnology Companies
  • Hospital
  • Research Institutions
  • Academic Institutions
  • Other
Companies covered
  • Takeda Pharmaceuticals Company
  • Sanofi
  • Novartis
  • Merck
  • Lanzhou Institute of Biologica
  • GlaxoSmithKline
  • Walvax Biotechnology
  • Immunize BC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Haemophilus Influenzae Type B Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Haemophilus Influenzae Type B Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Haemophilus Influenzae Type B Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Haemophilus Influenzae Type B Vaccine Market Dynamics
  1. 2.1 Haemophilus Influenzae Type B Vaccine Industry Trends
  2. 2.2 Haemophilus Influenzae Type B Vaccine Industry Drivers
  3. 2.3 Haemophilus Influenzae Type B Vaccine Industry Opportunities and Challenges
  4. 2.4 Haemophilus Influenzae Type B Vaccine Industry Restraints
3 Haemophilus Influenzae Type B Vaccine Market by Manufacturers
  1. 3.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Haemophilus Influenzae Type B Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Haemophilus Influenzae Type B Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Haemophilus Influenzae Type B Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Haemophilus Influenzae Type B Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Haemophilus Influenzae Type B Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Haemophilus Influenzae Type B Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Haemophilus Influenzae Type B Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Haemophilus Influenzae Type B Vaccine Tier 1, Tier 2, and Tier 3
4 Haemophilus Influenzae Type B Vaccine Market by Type
  1. 4.1 Haemophilus Influenzae Type B Vaccine Type Introduction
  2. 4.1.1 Liquid Combination HIB
  3. 4.1.2 Liquid Monovalent HIB
  4. 4.1.3 Lyophilized Combination HIB
  5. 4.1.4 Lyophilized Monovalent HIB
  6. 4.2 Global Haemophilus Influenzae Type B Vaccine Sales by Type
  7. 4.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2032)
  9. 4.2.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Type
  11. 4.3.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2032)
  13. 4.3.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2021-2032)
5 Haemophilus Influenzae Type B Vaccine Market by Application
  1. 5.1 Haemophilus Influenzae Type B Vaccine Application Introduction
  2. 5.1.1 Pharmaceutical and Biotechnology Companies
  3. 5.1.2 Hospital
  4. 5.1.3 Research Institutions
  5. 5.1.4 Academic Institutions
  6. 5.1.5 Other
  7. 5.2 Global Haemophilus Influenzae Type B Vaccine Sales by Application
  8. 5.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2032)
  10. 5.2.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2021-2032)
  11. 5.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Application
  12. 5.3.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2032)
  14. 5.3.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2021-2032)
6 Global Haemophilus Influenzae Type B Vaccine Sales by Region
  1. 6.1 Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Haemophilus Influenzae Type B Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Haemophilus Influenzae Type B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Haemophilus Influenzae Type B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Haemophilus Influenzae Type B Vaccine Revenue by Region
  1. 7.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Region
  2. 7.1.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Haemophilus Influenzae Type B Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Haemophilus Influenzae Type B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Haemophilus Influenzae Type B Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Haemophilus Influenzae Type B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceuticals Company
  2. 8.1.1 Takeda Pharmaceuticals Company Company Information
  3. 8.1.2 Takeda Pharmaceuticals Company Business Overview
  4. 8.1.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolio
  6. 8.1.5 Takeda Pharmaceuticals Company Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Haemophilus Influenzae Type B Vaccine Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Haemophilus Influenzae Type B Vaccine Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Lanzhou Institute of Biologica
  26. 8.5.1 Lanzhou Institute of Biologica Company Information
  27. 8.5.2 Lanzhou Institute of Biologica Business Overview
  28. 8.5.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolio
  30. 8.5.5 Lanzhou Institute of Biologica Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Walvax Biotechnology
  38. 8.7.1 Walvax Biotechnology Company Information
  39. 8.7.2 Walvax Biotechnology Business Overview
  40. 8.7.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolio
  42. 8.7.5 Walvax Biotechnology Recent Developments
  43. 8.8 Immunize BC
  44. 8.8.1 Immunize BC Company Information
  45. 8.8.2 Immunize BC Business Overview
  46. 8.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolio
  48. 8.8.5 Immunize BC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Haemophilus Influenzae Type B Vaccine Value Chain Analysis
  2. 9.1.1 Haemophilus Influenzae Type B Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Haemophilus Influenzae Type B Vaccine Production Mode & Process
  6. 9.2 Haemophilus Influenzae Type B Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Haemophilus Influenzae Type B Vaccine Distributors
  9. 9.2.3 Haemophilus Influenzae Type B Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst